Clinical Trial Update: What Should be the Next Vasopressor for Severe Septic Shock? Methylene Blue or Terlipressin [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing methylene blue versus terlipressin as vasopressors for severe septic shock is ongoing; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Septic Shock

Drugs mentioned

• METHYLENE BLUE (METHYLENE BLUE)
• Terlipressin (terlipressin)

Snippet

Sponsor: Ramathibodi Hospital | Conditions: Septic Shock, Refractory Shock | Phase 3 | Status: UNKNOWN